This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2010 May;128(5):636-8.

doi: 10.1001/archophthalmol.2010.53.

Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4

Steven P Dunn¹, David G Heidemann, Christopher Y C Chow, David Crockford, Nabila Turjman, Janet Angel, Christian B Allan, Gabriel Sosne

Affiliations

PMID: 20457990
DOI: 10.1001/archophthalmol.2010.53

Case Reports

Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4

Steven P Dunn et al. Arch Ophthalmol. 2010 May.

. 2010 May;128(5):636-8.

doi: 10.1001/archophthalmol.2010.53.

Authors

Steven P Dunn¹, David G Heidemann, Christopher Y C Chow, David Crockford, Nabila Turjman, Janet Angel, Christian B Allan, Gabriel Sosne

Affiliation

¹ Departments of Ophthalmology, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University, Detroit, USA. stevenpdunn@ameritech.net

PMID: 20457990
DOI: 10.1001/archophthalmol.2010.53

No abstract available

PubMed Disclaimer

Similar articles

Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta4.
Dunn SP, Heidemann DG, Chow CY, Crockford D, Turjman N, Angel J, Allan CB, Sosne G. Dunn SP, et al. Ann N Y Acad Sci. 2010 Apr;1194:199-206. doi: 10.1111/j.1749-6632.2010.05471.x. Ann N Y Acad Sci. 2010. PMID: 20536469 Review.
The successful use of Boston ocular surface prosthesis in the treatment of persistent corneal epithelial defect after herpes zoster ophthalmicus.
Gumus K, Gire A, Pflugfelder SC. Gumus K, et al. Cornea. 2010 Dec;29(12):1465-8. doi: 10.1097/ICO.0b013e3181da58b9. Cornea. 2010. PMID: 20847682
Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
Yamada N, Matsuda R, Morishige N, Yanai R, Chikama TI, Nishida T, Ishimitsu T, Kamiya A. Yamada N, et al. Br J Ophthalmol. 2008 Jul;92(7):896-900. doi: 10.1136/bjo.2007.130013. Epub 2008 May 29. Br J Ophthalmol. 2008. PMID: 18511539 Clinical Trial.
Substance P, insulinlike growth factor 1, and surface healing.
Lee CH, Whiteman AL, Murphy CJ, Barney NP, Taylor PB, Reid TW. Lee CH, et al. Arch Ophthalmol. 2002 Feb;120(2):215-7. Arch Ophthalmol. 2002. PMID: 11831929 No abstract available.
Advances in treatment for neurotrophic keratopathy.
Nishida T, Yanai R. Nishida T, et al. Curr Opin Ophthalmol. 2009 Jul;20(4):276-81. doi: 10.1097/icu.0b013e32832b758f. Curr Opin Ophthalmol. 2009. PMID: 19537364 Review.

See all similar articles

Cited by

Diabetic complications in the cornea.
Ljubimov AV. Ljubimov AV. Vision Res. 2017 Oct;139:138-152. doi: 10.1016/j.visres.2017.03.002. Epub 2017 Apr 28. Vision Res. 2017. PMID: 28404521 Free PMC article. Review.
Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis.
Wang Y, Carion TW, Ebrahim AS, Sosne G, Berger EA. Wang Y, et al. Int J Mol Sci. 2021 Oct 13;22(20):11016. doi: 10.3390/ijms222011016. Int J Mol Sci. 2021. PMID: 34681676 Free PMC article.
Differential contributions of impaired corneal sensitivity and reduced tear secretion to corneal epithelial disorders.
Nishida T, Chikama T, Sawa M, Miyata K, Matsui T, Shigeta K. Nishida T, et al. Jpn J Ophthalmol. 2012 Jan;56(1):20-5. doi: 10.1007/s10384-011-0105-4. Epub 2011 Nov 11. Jpn J Ophthalmol. 2012. PMID: 22071673 Clinical Trial.
Current and Emerging Therapeutic Strategies for the Management of Neurotrophic Keratitis.
Lacorzana J, Neo YN, Maubon L, Sibley D, Ahmad S. Lacorzana J, et al. Drugs. 2025 Mar;85(3):283-291. doi: 10.1007/s40265-025-02147-3. Epub 2025 Jan 23. Drugs. 2025. PMID: 39843756 Review.
Herpes zoster ophthalmicus.
Sanjay S, Huang P, Lavanya R. Sanjay S, et al. Curr Treat Options Neurol. 2011 Feb;13(1):79-91. doi: 10.1007/s11940-010-0098-1. Curr Treat Options Neurol. 2011. PMID: 21063920

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information